Here are the Form 4 insider transactions from PACS Group, Inc. (PACS) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow PACS and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full PACS filings page.
PACS Group, Inc. reported that director Patrick Hugh Conway acquired 3,497 restricted stock units (RSUs) of Common Stock as a grant. Each RSU represents the right to receive one share of Common Stock upon vesting. According to the terms, 100% of the RSUs will vest on the earlier of March 4, 2027 or the next annual meeting following the grant date, subject to his continued service to the company.
PACS Group, Inc. reported that Chief Compliance Officer Kelly Priegnitz received an award of 30,000 shares of common stock in the form of restricted stock units. Each RSU converts into one share upon vesting. The RSUs vest in substantially equal annual installments on the first, second, and third anniversaries of December 1, 2025, contingent on continued service.
PACS Group, Inc. reported that Chief Human Resources Officer Trent Dean Bingham received a grant of 25,000 shares of Common Stock in the form of restricted stock units. Each RSU converts into one share upon vesting, in substantially equal annual installments on the first, second, and third anniversaries of November 10, 2025, contingent on continued service.
PACS Group, Inc. Chief Accounting Officer reports tax withholding share transaction. Michelle Renee Lewis reported that on 01/15/2026, 3,348 shares of PACS Group, Inc. common stock were withheld at a price of $39.49 per share. The filing explains this was a payment of tax liability through the withholding of shares upon the vesting of previously granted and reported restricted stock units. After this transaction, Lewis beneficially owned 374,870 shares of PACS Group, Inc. common stock, held directly.
PACS Group, Inc. Chief Legal Officer and Secretary John Todd Mitchell reported a Form 4 transaction involving company common stock. On 01/15/2026, 9,541 shares of PACS Group common stock were withheld at a price of $39.49 per share. According to the footnote, this was a payment of tax liability through the withholding of shares upon the vesting of previously granted and reported restricted stock units, rather than an open-market sale. Following this tax withholding, Mitchell directly beneficially owned 868,150 shares of PACS Group common stock.
PACS Group, Inc. President & COO Joshua Jergensen reported a routine tax-withholding transaction in company common stock. On January 15, 2026, 21,998 shares of PACS Group common stock were withheld at a reference price of $39.49 per share, coded as an "F" transaction, which the disclosure explains was to pay tax liabilities arising from the vesting of previously granted restricted stock units.
Following this withholding, Jergensen beneficially owns 2,703,682 shares of PACS Group common stock, held directly. This filing reflects administrative share withholding for taxes rather than an open-market sale.
PACS Group, Inc. reported an insider equity transaction by Mark Hancock, a director, co-founder, interim CFO, executive vice chair, and 10% owner. On January 15, 2026, 12,774 shares of common stock were withheld at $39.49 per share to satisfy tax liabilities arising from the vesting of previously granted and reported restricted stock units. This was recorded as a disposition under code F, which denotes tax withholding rather than an open-market sale. Following this transaction, Hancock beneficially owns 54,804,443 shares of PACS Group common stock in direct ownership.
PACS Group, Inc. insider activity: Co-Founder, CEO and Chairman Murray Jason Hulse reported a tax-related share withholding tied to vested restricted stock units. On 01/15/2026, 20,082 shares of common stock were withheld at a price of $39.49 per share to satisfy tax liabilities upon vesting of previously granted and reported restricted stock units, as described in the footnote. After this transaction, Hulse beneficially owned 54,847,135 shares of PACS Group common stock in direct form.
PACS Group, Inc. reported that one of its directors received a grant of restricted stock units on December 19, 2025. The grant covers 4,399 RSUs, each representing the right to receive one share of PACS Group common stock when it vests, at a grant price of $0 per unit.
After this award, the director beneficially owns 10,837 shares of common stock in total. The RSUs will vest 100% on the earlier of December 19, 2026 or the date of the next annual meeting following the grant, as long as the director continues to serve the company.
PACS Group, Inc. reported an insider equity award for one of its directors. On 12/19/2025, the director acquired 4,399 restricted stock units (RSUs) of PACS Group common stock at a price of $0 per unit as reported on a Form 4. Each RSU entitles the holder to receive one share of common stock upon vesting.
The filing states that 100% of the RSUs will vest on the earlier of December 19, 2026 or the date of the next annual meeting following the grant date, provided the director continues to serve the company. Following this award, the director beneficially owns 27,138 shares of PACS Group common stock in total.
PACS Group, Inc. reported that one of its directors acquired additional equity through a new grant of restricted stock units. On December 19, 2025, the director received 4,399 RSUs of common stock at a price of $0 per unit, reflecting an equity award rather than an open‑market purchase. After this grant, the director beneficially owns 11,270 shares of PACS Group common stock in total.
The RSUs entitle the director to receive one share of common stock for each unit upon vesting. According to the award terms, 100% of the RSUs will vest on the earlier of December 19, 2026 or the date of the next annual meeting following the grant date, as long as the director continues to serve the company through that time.
PACS Group, Inc. reported an insider equity award for its Chief Accounting Officer on December 17, 2025. The officer acquired 32,500 shares of common stock tied to restricted stock units (RSUs) at a price of $0 and an additional 19,127 shares tied to RSUs, also at $0, as part of equity compensation.
The first RSU grant of 32,500 units will vest in substantially equal annual installments on the first, second, and third anniversaries of January 15, 2025, subject to continued service. The second RSU grant of 19,127 units will vest in substantially equal annual installments on the first, second, and third anniversaries of November 25, 2025, also subject to the officer remaining in service. Following these transactions, the officer beneficially owns 378,218 shares of common stock directly.
PACS Group, Inc. reported that its Chief Legal Officer and Secretary received new equity awards in the form of restricted stock units (RSUs). On 12/17/2025, the officer acquired 100,000 shares of common stock at a price of $0 and an additional 21,855 shares at a price of $0, both reported as RSU grants. One RSU award vests in substantially equal annual installments on the first, second, and third anniversaries of January 15, 2025, and the other vests in substantially equal annual installments on the first, second, and third anniversaries of November 25, 2025, in each case subject to continued service. Following these transactions, the officer beneficially owns 877,691 shares of common stock directly.
PACS Group, Inc. reported an insider equity award for its President & Chief Operating Officer. On December 17, 2025, the executive received 175,000 shares of common stock in the form of restricted stock units (RSUs) at a price of $0. These RSUs vest in three substantially equal annual installments on the first, second, and third anniversaries of January 15, 2025, contingent on continued service.
On the same date, the executive also received an additional 41,018 RSUs at $0, vesting in three substantially equal annual installments on the first, second, and third anniversaries of November 25, 2025, also subject to continued service. Following these equity grants, the executive beneficially owns 2,725,680 shares of PACS Group common stock directly.
PACS Group, Inc. insider and co-founder, who serves as interim CFO and executive vice chair and is also a director and 10% owner, reported new equity awards in the form of restricted stock units (RSUs). On 12/17/2025, the insider was granted 150,000 RSUs of common stock at a price of $0, and a separate grant of 41,018 RSUs of common stock, also at $0. After these awards, the insider beneficially owned 54,817,217 shares of common stock.
The 150,000 RSUs will vest in substantially equal annual installments on the first, second, and third anniversaries of January 15, 2025, subject to continued service. The 41,018 RSUs will vest in substantially equal annual installments on the first, second, and third anniversaries of November 25, 2025, also subject to continued service. Each RSU converts into one share of common stock upon vesting, so these grants increase the insider’s future equity exposure to PACS Group, Inc. over the multi‑year vesting period.
PACS Group, Inc. reported an insider equity award for its Co-Founder, CEO, Chairman and director, who is also a 10% owner. On December 17, 2025, the reporting person acquired 200,000 shares of common stock through restricted stock units and an additional 41,018 restricted stock units, both at a price of $0 per share.
The 200,000 RSUs vest in substantially equal annual installments on the first, second and third anniversaries of January 15, 2025, while the 41,018 RSUs vest in substantially equal annual installments on the first, second and third anniversaries of November 25, 2025, in each case subject to continued service. Following these transactions, the reporting person beneficially owns 54,867,217 shares of PACS Group common stock directly.
PACS Group, Inc. director share purchase disclosed
A director of PACS Group, Inc. (PACS) reported buying common stock in an open-market transaction. On 11/24/2025, the reporting person purchased 16,724 shares of PACS common stock at a weighted average price of $29.897 per share, with individual trades executed between $29.59 and $30.16. After this transaction, the director beneficially owned 22,739 shares directly. The filing notes that detailed trade-by-trade pricing information within this range is available upon request.
PACS Group, Inc. officer reports sale of common stock
A PACS Group, Inc. officer, serving as Chief Legal Officer and Secretary, reported selling 159,556 shares of PACS common stock on 11/24/2025. The transaction was coded "S," indicating an open-market or private sale. The weighted average sale price was $29.8853 per share, with individual trades executed between $29.54 and $30.125 per share. Following this sale, the officer beneficially owns 755,836 PACS common shares directly.
The filer notes a willingness to provide details on the number of shares sold at each individual price within the reported range upon request.